Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001178670-24-000053
Filing Date
2024-10-31
Accepted
2024-10-31 08:22:09
Documents
77
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q alny-20240930.htm   iXBRL 10-Q 2019948
2 EX-10.1 alny2024q310-qex101.htm EX-10.1 23756
3 EX-31.1 alny2024q310-qex311.htm EX-31.1 9317
4 EX-31.2 alny2024q310-qex312.htm EX-31.2 9305
5 EX-32.1 alny2024q310-qex321.htm EX-32.1 4156
6 EX-32.2 alny2024q310-qex322.htm EX-32.2 4157
12 GRAPHIC alny-20240930_g1.jpg GRAPHIC 437956
  Complete submission text file 0001178670-24-000053.txt   9607084

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT alny-20240930.xsd EX-101.SCH 57623
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT alny-20240930_cal.xml EX-101.CAL 68609
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT alny-20240930_def.xml EX-101.DEF 266910
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT alny-20240930_lab.xml EX-101.LAB 612342
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT alny-20240930_pre.xml EX-101.PRE 450549
80 EXTRACTED XBRL INSTANCE DOCUMENT alny-20240930_htm.xml XML 1422147
Mailing Address 675 WEST KENDALL STREET HENRI A. TERMEER SQUARE CAMBRIDGE MA 02142
Business Address 675 WEST KENDALL STREET HENRI A. TERMEER SQUARE CAMBRIDGE MA 02142 (617) 551-8200
ALNYLAM PHARMACEUTICALS, INC. (Filer) CIK: 0001178670 (see all company filings)

EIN.: 770602661 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36407 | Film No.: 241412575
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)